New Delhi, May 27, 2017: Natco Pharma BSE 0.78 % has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.
The proposal is to increase the production capacity of 66 Active Pharmaceutical Ingredients (APIs) and API intermediates at a time with research and development activity from 115.5 tonnes per annum (TPA) to 645 TPA in the existing land area of 34.17 hectare at Mekaguda village in Rangareddy district.
“The Environment Ministry has given the final environment clearance to Natco Pharma Ltd for expansion project. The approval has been given based on the recommendations of its expert ..
The Hyderabad-based company manufactures APIs in bulk quantities for both domestic and global markets. Its products are used in pharmaceutical formulation industry and manufacturing of therapeutic medicines like anti-depressant and anti-psychotic drugs, among others.
Natco Pharma, set up in 1981, has five manufacturing facilities in India. Natco group currently has more than 3,000 emp.
PTI. And Economic Times
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…